Patent Owner's Notice Of Appeal | Jul 14, 2017 | PAPER | PATENT OWNER |
Final Written Decision | May 16, 2017 | PAPER | BOARD |
Record of Oral Hearing | Mar 23, 2017 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Feb 13, 2017 | PAPER | PETITIONER |
Patent Owner's Fifth Updated Mandatory Notices | Feb 10, 2017 | PAPER | PATENT OWNER |
Decision Granting Pro Hac Vice Motions | Feb 10, 2017 | PAPER | BOARD |
Petitioner's Motion for Pro Hac Vice Admission | Feb 3, 2017 | PAPER | PETITIONER |
Declaration of Jon Singer in Support of Pro Hac Vice Admission | Feb 3, 2017 | EXHIBIT | PETITIONER |
Order Trial Hearing | Feb 2, 2017 | PAPER | BOARD |
Petitioner's Revised Reply | Jan 23, 2017 | PAPER | PETITIONER |
Conduct of the Proceeding | Jan 20, 2017 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Jan 20, 2017 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Jan 20, 2017 | PAPER | PETITIONER |
Rau, AKT RHEUMATOL (2000) (German Original) (High-resolution Version) | Jan 19, 2017 | EXHIBIT | PATENT OWNER |
Transcript of January 17, 2017 Conference Call | Jan 19, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jan 19, 2017 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence | Jan 5, 2017 | PAPER | PATENT OWNER |
Petitioner's Reply | Dec 28, 2016 | PAPER | PETITIONER |
Pediatric Psychopharmacology Principles | Dec 28, 2016 | EXHIBIT | PETITIONER |
Neonatal and Pedatric Pharmacology | Dec 28, 2016 | EXHIBIT | PETITIONER |
Review Article: Applying Pharmacokinetics to Optimise Dosing of Anti-TNF Biologics in Acute Severe Ulcerative Colitis | Dec 28, 2016 | EXHIBIT | PETITIONER |
Pharma¿¿¿s Ad Spend Vaults to $4.5B, With Big Spender Pfizer Leading the Way | Dec 28, 2016 | EXHIBIT | PETITIONER |
Drug Makers Now Spend $5 Billion A Year On Advertising | Dec 28, 2016 | EXHIBIT | PETITIONER |
Development and Validation of the European League Against Rheumatism Response Criteria for Rheumatoid Arthritis | Dec 28, 2016 | EXHIBIT | PETITIONER |
Figure 2 of the Van Gestel Chart | Dec 28, 2016 | EXHIBIT | PETITIONER |
Deposition transcript of Brian E. Harvey, M.D. | Dec 28, 2016 | EXHIBIT | PETITIONER |
Deposition transcript of Alexander A. Vinks, Ph.D. | Dec 28, 2016 | EXHIBIT | PETITIONER |
Deposition transcript of Jeffrey M. Sailstad | Dec 28, 2016 | EXHIBIT | PETITIONER |
Deposition transcript of Allan Gibofsky, M.D. | Dec 28, 2016 | EXHIBIT | PETITIONER |
Pharmacokinetics & Protein Therapeutics | Dec 28, 2016 | EXHIBIT | PETITIONER |
Comparative Pharmacokinetics of the Carbapenems: Clinical Implications | Dec 28, 2016 | EXHIBIT | PETITIONER |
Birth of a Blockbuster | Dec 28, 2016 | EXHIBIT | PETITIONER |
Patent Owner's Preliminary Response | Dec 28, 2016 | EXHIBIT | PETITIONER |
AbbVie Patent List | Dec 28, 2016 | EXHIBIT | PETITIONER |
Optimizing Clinical Outcomes in Rheumatoid Arthritis | Dec 28, 2016 | EXHIBIT | PETITIONER |
Current Therapeutic Agents and Treatment Paradigms for the Management of Rheumatoid Arthritis | Dec 28, 2016 | EXHIBIT | PETITIONER |
Deposition transcript of Jerry A. Hausman, Ph.D. | Dec 28, 2016 | EXHIBIT | PETITIONER |
Updated Notice of Deposition of Dr. Alexander A. Vinks | Nov 1, 2016 | PAPER | PETITIONER |
Updated Notice of Deposition of Dr. Allan Gibofsky | Nov 1, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Mr. Jeffrey M. Sailstad | Oct 13, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Alexander A. Vinks | Oct 13, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Allan Gibofsky | Oct 13, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Brian E. Harvey | Oct 13, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Dr. Jerry A. Hausman | Oct 13, 2016 | PAPER | PETITIONER |
Petitioner's Objections to Evidence | Sep 20, 2016 | PAPER | PETITIONER |
Patent Owner's Response | Sep 13, 2016 | PAPER | PATENT OWNER |
Lobb (2007) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Sep 13, 2016 | PAPER | PATENT OWNER |
Notices of Deposition of Brian Reisetter | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Exhibit M to Williams Declaration (Feb. 7, 2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Exhibit D to the Williams Declaration (Feb. 7, 2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
CVS Caremark Primary/Preferred Drug List (Oct. 2010) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
2004 Express Scripts Nat'l Preferred Alpha Formulary List (Dec. 29, 2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
UnitedHealthcare 2013 Prescription Drug List Quick-Reference Guide | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2013) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Notices of Deposition of Sharon Baughman | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Feldmann & Maini, ANNU. REV. IMMUNOL. (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Baughman, PK/PD Study Strategies for Biopharmaceuticals (Oct. 14, 2009) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Trastuzumab/HERCEPTIN label (Mar. 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Proudfoot (2002) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Denosumab/PROLIATM label (Jun. 2010) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Baselga, SEMIN. ONCOL. (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Cai (2011) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Furst (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Notices of Deposition of James O¿¿¿Dell | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Wolfe, J. RHEUMATOL. (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, CLIN. EXP. RHEUMATOL. (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ARTHRITIS & RHEUMATISM (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ANN. RHEUM. DIS. (1996) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, MAYO CLIN. PROC. (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Ziminski, MD, AM. J. OF MANAGED CARE (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Jeffrey M. Sailstad | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, NEW ENG. J. MED. (1996) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2007) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, ARTHRITIS & RHEUMATISM (2011) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
O¿¿¿Dell, CURRENT RHEUMATOLOGY REPORTS (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Allan Gibofsky | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Brian Harvey | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Jerry A. Hausman | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Alexander A. Vinks | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of Brian Reisetter (Jul. 12, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Errata for Transcript of Depo. of Brian Reisetter (Jul. 12, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Errata for Transcript of Depo. of Sharon Baughman (Aug. 2, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of James O¿¿¿Dell (Sept. 1, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of Sharon Baughman (Aug. 2, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Ruderman & Tambar, Rheumatoid Arthritis | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Clark, IMMUNOLOGY TODAY (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Eckardt & Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Guidance for Industry (Feb. 1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Kavanaugh, RHEUMATIC DISEASE CLINICS OF N. AM. (1998) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Christen, HUMAN IMMUNOLOGY (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Points to Consider (Feb. 28, 1997) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Findlay, J. PHARM. BIOMED. ANAL. (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Furst, Arthritis & Rheumatism (1996) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Furst, J. RHEUMATOL. (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Furst, ANN. RHEUM. DIS. (2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Gibofsky, AM. J. MEDICINE (1997) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Hanauer, AILMENT PHARMACOL. THER. (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Hasler, (1996) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Smolen, ANN. RHEUM. DIS. (2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Gibofsky, CURRENT MED. RES. & OP.(2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Allan Gibofsky | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter, Adalimumab (HUMIRA) (Dec. 31, 2002) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Adalimumab (HUMIRA)Package Insert (Dec. 2002) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Guidance for Industry (Apr. 1996) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Ruffing & Bingham, Rheumatoid Arthritis Signs and Symptoms | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Bingham & Ruffing, Rheumatoid Arthritis Treatment | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Maini & Feldmann, ARTHRITIS RES. (2002) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Mayo Clinic Staff, Rheumatoid arthritis | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Karlsson, BR. J. CLIN. PHARMACOL. (1998) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
The Lenercept MS Study Group, NEUROLOGY (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Miller, PHARMACEUTICAL RESEARCH (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Mire-Sluis, J. IMMUNOLOGICAL METHODS (2004) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Moreland, ARTHRITIS & RHEUMATISM (1997) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Mevorach & Paget (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Mordenti, TOXICOLOGIC PATHOLOGY (1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Moreland, J. RHEUMATOL. (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
MW\PHARM Ver. 3.15, Vols. 1-3 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rheumatoid Arthritis: What is Rheumatoid Arthritis? | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Nestorov, J. RHEUMATOL. (2005) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Prevoo, ARTHRITIS & RHEUMATISM (1995) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rau, AKT RHEUMATOL (2000) (German Original) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rowland & Tozer (2011) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Sailstad, THE AAPS JOURNAL (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Smolen, ANN. RHEUM. DIS. (2013) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rankin, BR. J. RHEUMATOL. (1995) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rau, AKT RHEUMATOL (2000) (English Translation) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Review of BLA submission 99-O 128(Oct. 22, 1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Ross, ANN. NEUROL. (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rossert, J. AM. SOC. NEPHROL. (2004) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rowland & Tozer (1995) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Jeff Sailstad | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Sander & Rau, INT¿¿¿L J. CLIN. PHARM. THERAPEUTICS (1998) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Sedger & McDermott, CYTOKINE & GROWTH FACTOR REVIEWS (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Stephens, IMMUNOLOGY (1995) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Taylor, ARTHRITIS & RHEUMATISM (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Tishler, ANN. RHEUM. DIS. (1992) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
van de Putte, ANN. RHEUM. DIS. (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Alexander A. Vinks | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Jerry A. Hausman | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
van de Putte, ANN. RHEUM. DIS. (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Weaver, CURRENT MED. RES. & OP. (2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Weinblatt, TRANSACTIONS OF THE AM. CLIN. & CLIMATOLOGICAL ASS'n (2013) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
MwPharm ver. 3.82 (update of ver. 3.60) (Feb. 16, 2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 125057/45 (Oct. 3, 2005) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Summary Review of sBLA 125057/110 (Jan. 16, 2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 12057/89 (Feb. 27, 2007) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 125057/110 (Jan, 18, 2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/232 (Sept. 28, 2012) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/S-363 (Sept. 9, 2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/S-397 (June 30, 2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for sBLA 125057/114 (Feb. 21, 2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
GlobalData, Top 50 pharmaceutical products by global sales | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for 99-0128 (Nov. 10, 1999) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Certolizumab pegol/CIMZIA label (Nov. 18, 2009) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Golimumab/SIMPONI label (Apr. 2009) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2005) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Anantharaman, FROST & SULLIVAN (July 20, 2004) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Palmer, Top 10 rheumatoid arthritis drugs 2013 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Berndt (1997) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
U.S. FDA, How Drugs are Developed and Approved | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Chilton & Collett, MUSCULOSKELET. CARE (2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Abbott Labs., Press Release (June 26, 2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Navarro-Mill¿¿n, PLOS ONE (2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Approval Letter for BL 103795/5110 (Oct. 17, 2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Louder, AM. HEALTH DRUG BENEFITS (2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Lisicki & Chu, POSTGRADUATE MEDICINE (2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Greenapple, AM. HEALTH DRUG BENEFITS (2012) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curtis, & Singh, CLIN. THER. (2011) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Williams & Edwards, RHEUMATOLOGY (2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Sylwestrzak, AM. HEALTH DRUG BENEFITS (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Huynh, PATIENT PREFERENCES AND ADHERENCE (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Abbott, Introducing More Reasons Than Ever To Choose Humira | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Neef & Vinks, PHARMACEUTICS WEEKLY (2000) (English Translation) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Neef & Vinks, PHARMACEUTISCH WEEKBLAD (2000) (Dutch Original) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Brian E. Harvey | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Abbott Labs., Helping Your RA Patients Live More Normal Lives | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Amgen, Press Release (July 20, 2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Supplemental Approval Letter for BLA 125057/356 (Sept. 23, 2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Clowse, 2015 ACR/ARHP ANNUAL MEETING (2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
DiMasi, J. HEALTH ECON. (2003) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Statement of Janet Woodcock (May 2, 2007) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Hamilton, CONTROLLED CLIN. TRIALS (2000) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
D¿¿rner, ARTHRITIS RESEARCH THERAPY (2006) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Emery, PLOS ONE (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Genovese, ANN RHEUM DIS (2013) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Genovese, ARTHRITIS & RHEUM. (2008) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Sacks, JAMA (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00077870 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00090129 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00406419 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00485589 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00785928 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00476996 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00624351 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT00673920 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01198002 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01261793 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT01262365 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
ClinicalTrials.gov identifier NCT02720120 | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
UCB Pharma Press Release, (Jul. 28, 2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Papp, CURRENT MED. RES. & OP. (2010) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2013 (Fed. 3, 2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rigby, ARTHRITIS & RHEUM. (2012) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Tak, ARTHRITIS & RHEUM. (2012) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Torgerson, CONTROL. CLIN. TRIALS (2001) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2012 (Feb. 5, 2013) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Philippidis, Top 10 Clinical Trial Failures of 2014 (Feb. 9, 2015) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Rayes & Touma, DRUG DESIGN, DEVELOPMENT AND THERAPY (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Wallace, ARTHRITIS CARE & RES. (2016) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Wallace, ANN. RHEUM. DIS. (2014) | Sep 13, 2016 | EXHIBIT | PATENT OWNER |
Notice of Deposition of James O'Dell, M.D. | Aug 11, 2016 | PAPER | PATENT OWNER |
Petitioner's Notice of Designation of Additional Back-Up Counsel | Jul 28, 2016 | PAPER | PETITIONER |
ERRATA | Jul 28, 2016 | PAPER | BOARD |
Patent Owner's Power of Attorney | Jul 25, 2016 | PAPER | PATENT OWNER |
Patent Owner's Fourth Updated Mandatory Notices | Jul 25, 2016 | PAPER | PATENT OWNER |
Order - PO's Pro Hac Vice Motion for William McElwain and Amy Wigmore | Jul 20, 2016 | PAPER | BOARD |
Declaration of Amy K. Wigmore | Jul 20, 2016 | EXHIBIT | PATENT OWNER |
Declaration of William G. McElwain | Jul 20, 2016 | EXHIBIT | PATENT OWNER |
Notice of Deposition of Sharon Baughman, Ph.D. | Jul 13, 2016 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Amy K. Wigmore | Jul 12, 2016 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of William G. McElwain | Jul 12, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jul 12, 2016 | PAPER | PATENT OWNER |
Exhibit 2034 - Declaration of William G. McElwain | Jul 12, 2016 | PAPER | PATENT OWNER |
Exhibit 2035 - Declaration of Amy K. Wigmore | Jul 12, 2016 | PAPER | PATENT OWNER |
Order- Petitioner's Motion for Pro Hac Vice Admission of John C. Adkisson | Jul 11, 2016 | PAPER | BOARD |
Petitioner's Motion for Pro Hac Vice Admission of John C. Adkisson | Jul 1, 2016 | PAPER | PETITIONER |
Declaration of John Adkisson in Support of Pro Hac Vice Admission | Jul 1, 2016 | EXHIBIT | PETITIONER |
Patent Owner's Third Updated Mandatory Notices | Jun 30, 2016 | PAPER | PATENT OWNER |
Order Revising the Schedule | Jun 30, 2016 | PAPER | BOARD |
Notice of Deposition of Brian Reisetter, Ph.D. | Jun 29, 2016 | PAPER | PATENT OWNER |
Decision - Denying Patent Owner's Request for Rehearing | Jun 29, 2016 | PAPER | BOARD |
Joint Proposal for a Stipulated Schedule | Jun 22, 2016 | PAPER | PATENT OWNER |
ORDER Conduct of the Proceeding | Jun 20, 2016 | PAPER | BOARD |
Patent Owner's List for Initial Conference Call | Jun 14, 2016 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence | Jun 1, 2016 | PAPER | PATENT OWNER |
Power of Attorney | May 26, 2016 | PAPER | PATENT OWNER |
Patent Owner's Second Updated Mandatory Notices | May 26, 2016 | PAPER | PATENT OWNER |
Patent Owner's Request for Rehearing | May 26, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | May 26, 2016 | PAPER | PATENT OWNER |
Exhibit 2032 - Nerozzi-Ankenbrand Profile | May 26, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2033 - Shear Profile | May 26, 2016 | EXHIBIT | PATENT OWNER |
Scheduling Order | May 18, 2016 | PAPER | BOARD |
Decision to Institute Inter Partes Review | May 17, 2016 | PAPER | BOARD |
Patent Owner's Updated Mandatory Notices | Feb 18, 2016 | PAPER | PATENT OWNER |
Patent Owner's Preliminary Response | Feb 18, 2016 | PAPER | PATENT OWNER |
Exhibit 2001 - Declaration of Janet Pope | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2002 - Declaration of Michael E. Weinblatt | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2003 - Declaration of Diane R. Mould | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2004 - Declaration of Mr. Medgar Williams | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2005 - Kupper I Declaration | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2006 - Kupper II Declaration | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2007 - Rituximab/RITUXAN label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2008 - Trastuzumab/HERCEPTIN label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2009 - Abciximab/REOPRO label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2010 - Daclizumab/ZENAPAX label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2011 - Basiliximab/SIMULECT label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2012 - Palivizumab/SYNAGIS label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2013 - Gemtuzumab/MYLOTARG label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2014 - Alemtuzumab/CAMPATH label | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2015 - Adalimumab M10-261 Clinical Study Report | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2016 - Kress (Dec. 24, 2002) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2017 - Rowland and Tozer (3d ed. 1995) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2018 - Porter and Charman (2000) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2019 - Rau (1999) (original German) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2020 - Rau (1999) (certified English translation) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2021 - van de Putte, et al. (2004) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2022 - Vincent, et al. (2013) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2023 - van Schouwenburg, et al. (2013) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2024 - Maini, et al. (1998) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2025 - Wolfe, et al. (2001) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2026 - O'Dell (G.C. Tsokos et al. ed. 2002) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2027 - An (2010) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2028 - Bross, et al. (June 2001) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2029 - Amendment and Response to Office Action (Jan. 29, 2008) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2030 - Direct Narrative Statement of Brian C. Reisetter | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Exhibit 2031 - Timmerman (Apr. 16, 2012) | Feb 18, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Mandatory Notices | Nov 24, 2015 | PAPER | PATENT OWNER |
Power of Attorney | Nov 23, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Expunged | Nov 18, 2015 | PAPER | BOARD |
Notice of Filing Date Accorded to Petition | Nov 18, 2015 | PAPER | BOARD |
Power of Attorney | Nov 9, 2015 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent 8,889,135 | Nov 9, 2015 | PAPER | PETITIONER |
U.S. Patent No. 8,889,135 | Nov 9, 2015 | EXHIBIT | PETITIONER |
U.S. Prosecution History of the 135 patent | Nov 9, 2015 | EXHIBIT | PETITIONER |
Preliminary results of early clinical trials with the fully human TNFa monoclonal antibody D2E7 | Nov 9, 2015 | EXHIBIT | PETITIONER |
Efficacy of the Fully Human Anti-TNF Antibody D2E7 in Rheumatoid Arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
Effective Combination of the Fully Human Anti-TNF Antibody D2E7 and Methotrexate in Active Rheumatoid Arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
Declaration of Dr. Sharon Baughman | Nov 9, 2015 | EXHIBIT | PETITIONER |
Declaration of Dr. James ODell | Nov 9, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,090,382 | Nov 9, 2015 | EXHIBIT | PETITIONER |
Long-term treatment with the fully human anti TNF alpha-antibody D2E7 slows radio-graphic disease progression in rheumatoid arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
Dorlands Illustrated Medical Dictionary | Nov 9, 2015 | EXHIBIT | PETITIONER |
Etanercept/ENBREL label (1998) | Nov 9, 2015 | EXHIBIT | PETITIONER |
Infliximab/REMICADE label (Nov. 1999) | Nov 9, 2015 | EXHIBIT | PETITIONER |
The Human IgG Subclasses | Nov 9, 2015 | EXHIBIT | PETITIONER |
Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo) | Nov 9, 2015 | EXHIBIT | PETITIONER |
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases | Nov 9, 2015 | EXHIBIT | PETITIONER |
Guidance for Industry, Clinical Development Programs for Drugs, Devices and Biological Products for the Treatment of Rheumatoid Arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
A Single Dose Placebo Controlled Phase I Study of the Fully Human Anti-TNF Antibody D2E7 in Patients with Rheumatoid Arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
Long-Term Efficacy and Tolerability of Multiple I.V. Doses of the Fully Human Anti-TNF-Antibody D2E7 in Patients with Rheumaoid Arthritis | Nov 9, 2015 | EXHIBIT | PETITIONER |
Efficacy and Tolerability of Weekly Subcutaneous Injections of the Fully Human Anti-TNF-Antibody D2E7 in Patiens with Rheumatoid Arthritis-Results of a Phase I Study | Nov 9, 2015 | EXHIBIT | PETITIONER |
ENBREL Summary Basis of Approval (1998) | Nov 9, 2015 | EXHIBIT | PETITIONER |
REMICADE Summary Basis of Approval (1999) | Nov 9, 2015 | EXHIBIT | PETITIONER |
WO98/004281 | Nov 9, 2015 | EXHIBIT | PETITIONER |
A dose escalation study designed to demonstrate the safety, tolerability and efficacy of the fully human anti-TNF antibody, D2E7, given in combination with methotrexate (MTX) in patients with active RA | Nov 9, 2015 | EXHIBIT | PETITIONER |
Arthritis and Rheum., vol. 42 | Nov 9, 2015 | EXHIBIT | PETITIONER |
Declaration of Dr. Brian Reisetter | Nov 9, 2015 | EXHIBIT | PETITIONER |
Exhibit L to Declaration of Medgar Williams | Nov 9, 2015 | EXHIBIT | PETITIONER |
Certolizumab/CIMZIA label (Revised July 2010) | Nov 9, 2015 | EXHIBIT | PETITIONER |
Golimumab/SIMPONI label (Revised Dec. 2011) | Nov 9, 2015 | EXHIBIT | PETITIONER |
MM and M 2014 Large Pharma Marketing Team of the Year Humira | Nov 9, 2015 | EXHIBIT | PETITIONER |
DTC Report DTC Gets Smart | Nov 9, 2015 | EXHIBIT | PETITIONER |
CVS/caremark Performance Drug List | Nov 9, 2015 | EXHIBIT | PETITIONER |
2015 Express Scripts Basic Formulary | Nov 9, 2015 | EXHIBIT | PETITIONER |
UnitedHealthcare 2015 Four-Tier Prescription Drug List | Nov 9, 2015 | EXHIBIT | PETITIONER |
Adalimumab/HUMIRA label | Nov 9, 2015 | EXHIBIT | PETITIONER |